STATE STREET CORP - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 62 filers reported holding OBALON THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$348,000
-38.4%
102,206
+19.8%
0.00%
Q4 2017$565,000
-19.4%
85,344
+16.2%
0.00%
Q3 2017$701,000
-0.6%
73,442
+3.1%
0.00%
Q2 2017$705,000
+53.6%
71,242
+66.1%
0.00%
Q1 2017$459,000
+52.0%
42,886
+25.9%
0.00%
Q4 2016$302,00034,0730.00%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 2,453,338$24,313,0005.76%
Tamarack Advisers, LP 528,066$5,233,0003.06%
LEVEL FOUR ADVISORY SERVICES, LLC 330,427$3,274,0000.50%
FORMULA GROWTH LTD 108,998$1,080,0000.19%
Moisand Fitzgerald Tamayo, LLC 6,842$268,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 183,086$1,814,0000.10%
KORNITZER CAPITAL MANAGEMENT INC /KS 422,410$4,186,0000.07%
TIVERTON ASSET MANAGEMENT LLC 130,050$1,289,0000.07%
Bellevue Group AG 45,000$446,0000.05%
Laird Norton Wetherby Wealth Management, LLC 24,038$238,0000.04%
View complete list of OBALON THERAPEUTICS INC shareholders